Federal contract award

HHSN26100039

IGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NCI
NAICS561210 — Facilities Support Services
PSCM1HA — OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES
Parent award / vehicleHHSN261201500003I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$19.8M
Current contract value$19.8M
Potential contract value / ceiling$19.8M
Start dateSep 28, 2017
Current end dateSep 30, 2026
Potential end dateSep 30, 2026
Latest award activityFeb 23, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Feb 23, 2026P00010$0RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS (MOONSHOT)
Sep 12, 2025P00009$-1.5MEOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
Apr 28, 2025P00008$0EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
Dec 13, 2023P00007$0RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS (MOONSHOT)
Jun 2, 2022P00006$0RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS (MOONSHOT)
Feb 2, 2022P00005$0RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS (MOONSHOT)
Mar 1, 2021P00004$0RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS (MOONSHOT)
Sep 18, 2019P00003$0RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS (MOONSHOT)
May 15, 2019P00002$0IGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS
Sep 12, 20181$8.4MIGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS
Sep 25, 20170$12.9MIGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.